Navigation Links
Diabetics Urged to Confer With Their Doctor About Avandia Use
Date:7/16/2010

By Amanda Gardner
HealthDay Reporter

THURSDAY, July 15 (HealthDay News) -- One day after a U.S. advisory panel recommended that the controversial diabetes drug Avandia stay on the market -- albeit with added restrictions -- several medical organizations are urging patients not to change their medications before consulting a health-care professional.

Some experts expect the use of Avandia to drop off markedly, however.

"Why give a drug with restrictions when a similar drug which has studies that did not show the bad outcomes of Avandia could be used instead," said Dr. Jacob Warman, chief of endocrinology at The Brooklyn Hospital Center in New York City. "I don't see anybody willing to take Avandia when they could take Actos."

Actos (pioglitazone) is a drug similar to Avandia, one of the same class of medications known as thiazolidinediones (TZDs).

On Wednesday, a U.S. Food and Drug Administration advisory panel voted that the blood sugar-lowering drug did raise the risk of heart attacks relative to other medications of its kind, though not the risk of death.

The 33-member panel ultimately voted that Avandia should stay on the market but with tightened controls.

Twelve members voted for removing the drug, 17 voted for new warning label revisions or restrictions on its use, and three voted that no changes were needed.

The FDA is not obligated to follow the advice of its advisory committees but usually does.

The safety of Avandia has been in question for years, rising to a point in 2007 when the FDA added a "black box" warning to the drug's packaging that noted the potential risk of increased cardiovascular events.

Both Avandia and Actos already had warnings regarding heart failure.

In a joint statement released Wednesday after the vote, the Endocrine Society, the American Diabetes Association and the American Association of Clinical Endocrinologists urged patients no
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Tight Blood Pressure Control Doesnt Help All Diabetics: Study
2. Tight Blood Sugar Control in Older Diabetics May Not Reduce Heart Risk
3. Many Diabetics Unaware of Hot Weather Hazards
4. Glucose Tattoo Could Track Blood Sugar Levels for Diabetics
5. Experts Advise At-Risk Diabetics to Begin Daily Aspirin Later
6. Frequent Doctor Visits Help Diabetics Control Blood Pressure
7. Pig Pancreas Cells Help Type 1 Diabetics
8. Healthy Pre-Diabetics Still Face Heart Disease Threat
9. Tight Blood Sugar Control May Not Harm Diabetics
10. High-Dose Vitamin B Risky for Diabetics With Kidney Disease
11. Discovery could help diabetics and others with slow-to-heal wounds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Diabetics Urged to Confer With Their Doctor About Avandia Use
(Date:7/29/2014)... CA (PRWEB) July 29, 2014 As the ... working with its partners to both purchase critical emergency supplies ... the US to Liberia. These supplies will contain materials used ... the most heavily populated areas of the country. , ... involved in the response to the Ebola outbreak in the ...
(Date:7/29/2014)... 29, 2014 The Board of Governors of ... Hart LLP ’s Connie Akridge to serve as ... as President of the Foundation. Akridge served as President of ... a partner at Holland & Hart in Las Vegas, providing ... matters to insurance and healthcare clients for more than 25 ...
(Date:7/29/2014)... 2014 CarePoint Health is proud ... our network, CarePoint Health Medical Group. Our system ... Hundreds of highly skilled and experienced physicians comprise ... top doctors and practices in Hudson County, representing ... represents CarePoint Health’s commitment to provide the highest ...
(Date:7/29/2014)... New York (PRWEB) July 29, 2014 ... behalf of individuals who allegedly suffered serious liver ... continue to move forward in a multidistrict litigation ... Pennsylvania, Bernstein Liebhard LLP reports. According to an ... certain deadlines pertaining to bellwether case and ...
(Date:7/29/2014)... Denham Springs, LA (PRWEB) July 29, 2014 ... long holiday across the United States usually celebrated throughout ... More recently though, those summer days now mark the ... increase in crashes involving teen drivers. In 2012 ... drivers during the period from Memorial Day to Labor ...
Breaking Medicine News(10 mins):Health News:PCI Responds to Ebola Outbreak in Liberia with Supplies, Awareness Campaigns 2Health News:PCI Responds to Ebola Outbreak in Liberia with Supplies, Awareness Campaigns 3Health News:Holland & Hart LLP Attorney Connie Akridge Reappointed Trustee of the Nevada Bar Foundation 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 3Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:Narconon New Life Retreat Launches New Alcohol Prevention Program 2
... As millions of emails by,faithful Christians circulate around ... weeping image of Jesus Christ at Florida Hospital,s ... an explanation,today: "Jesus was weeping at the deplorable ... billion-dollar religious hospital,operation run by millionaire executives that ...
... Blue Shield of,Minnesota (Blue Cross) today released its financial ... of 0.3 percent ($25.1 million) on,full-year revenues of $8.4 ... offset $104 million in operating losses. Blue,Cross remains financially ... claims and operating expenses., More than 90 cents ...
... THURSDAY, April 17 (HealthDay News) -- The antidepressant Prozac ... their more plastic youthful condition in animal experiments, researchers ... new explanation for the antidepressant activity of the medication ... be used to treat other conditions caused by malfunction ...
... WASHINGTON, April 17 The Better Hearing,Institute (BHI) announced ... ( http://www.hearingcheck.org ), a nationwide campaign to,help millions of ... to,unaddressed hearing loss. The campaign will serve as the ... during the month of May., Spouses, Baby Boomers ...
... to improve ... patient access, HARRISBURG, Pa., April ... of Philadelphia as,its new president. Dr. Gamba, who served as president-elect for ... be a major focus of the organization., "All Pennsylvanians deserve access ...
... (Nasdaq: CTGX ),an international information technology (IT) solutions ... 2008 first quarter,financial results on April 23, 2008 after ... to discuss its financial results and business,strategy on Thursday, ... and Chief Executive Officer James R. Boldt will lead ...
Cached Medicine News:Health News:Weeping Image of Jesus at Florida Hospital Explained 2Health News:Blue Cross and Blue Shield of Minnesota Releases 2007 Financial Results 2Health News:Prozac Makes Old Brain Cells Young 2Health News:Prozac Makes Old Brain Cells Young 3Health News:Better Hearing Institute Kicks Off the Across America Hearing Check Challenge for Better Hearing and Speech Month, Bringing Better Quality of Life Back to Millions of Americans 2Health News:New Pennsylvania Dental Association President Will Focus on Improving Access to Care 2Health News:New Pennsylvania Dental Association President Will Focus on Improving Access to Care 3Health News:CTG Announces 2008 First Quarter Conference Call and Webcast Information 2
(Date:7/29/2014)... July 29, 2014 Amgen (NASDAQ: ... quarter of 2014. Key results include: , Total ... percent product sales growth driven by strong performance across ... (carfilzomib), Prolia ® (denosumab) and XGEVA ® ... to $2.37, driven by higher revenues and a significant ...
(Date:7/29/2014)... Inc. (NASDAQ: SQNM ), a life sciences ... revenues of $39.8 million for the second quarter of ... $24.5 million for the second quarter of 2013. ... on May 30, 2014, has been accounted for as ... excluded from continuing operations for all periods. ...
(Date:7/29/2014)... July 29, 2014 Pfenex Inc. (NYSE MKT: PFNX) ... public offering of 8,333,333 shares of its common  stock at ... of the common stock was offered by Pfenex. In addition, ... up to 1,250,000 additional shares of common stock at the ... traded on the NYSE MKT under the symbol "PFNX." ...
Breaking Medicine Technology:Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 2Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 4Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 5Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 7Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 8Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 9Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 10Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 11Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 12Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 13Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 14Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 15Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 16Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 17Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 18Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 19Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 20Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 21Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 22Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 23Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 24Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 25Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 2Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 3Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 4Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 5Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 6Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 7Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 8Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 9Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 10Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 11Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 12
... role within the orthopaedic industry, DePuy Orthopaedics ... industry's leading fixed-bearing implant, the P.F.C. SIGMA ... clinically proven technology of the LCS Knee ... ,The result is the P.F.C. SIGMA RP ...
The Biopro Modular TKO implant is among the thinnest bone conserving Posterior Cruciate Ligament sparing knees available. It provides all the benefits of the Biopro TKO implant and gives the option o...
The design and concept of the Alpina knee allows the choice of implanting a PCL retaining or a posterior stabilized prosthesis intraoperatively, right up until the definitive implants are to be put i...
... The VersaPulse® PowerSuite™ holmium laser ... properties for precise, virtually bloodless procedures. ... fragmenting urinary and gall bladder stones ... ideal multipurpose surgical tool. Because its ...
Medicine Products: